ArticleThe Journal of clinical investigation2022

Is androgen receptor activity in metastatic prostate cancer a good biomarker for bipolar androgen therapy?

Nahuel Peinetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.